Suicidal ideation and behaviour and depression are low and within general psoriasis ranges in patients being treated with bimekizumab.

Dupilumab is safe and efficacious in treating moderate-to-severe AD in pediatric patients.

Phase III results presented during a late-breaking session at the annual meeting of the American Academy of Dermatology in San Diego,...

Biomarkers in the skin microbiota, antimicrobial peptides, and natural moisturizing factors m ay predict AD in infants.

Liquid synthetic detergents are better suited for maintaining healthy skin barrier function in AD patients.

The most effective AD treatments may also have the greatest risk of adverse events.

A multidisciplinary approach is most effective for treating difficult-to-control AD in children and adolescents.

A website that helps people with eczema manage their symptoms could be saving the U.K. National Health Service (NHS) hundreds of...